WuXi Biologics’ stock was trading 3.1 per cent lower in Hong Kong on Wednesday afternoon. Photo: Sam TsangWuXi Biologics’ stock was trading 3.1 per cent lower in Hong Kong on Wednesday afternoon. Photo: Sam Tsang
WuXi Biologics’ stock was trading 3.1 per cent lower in Hong Kong on Wednesday afternoon. Photo: Sam Tsang

Coronavirus drugs research firm WuXi Biologics’ largest shareholder sells stake for US$893 million windfall

  • WuXi Biologics Holdings raised HK$6.1 billion by selling a 2.43 per cent stake after the market closed on Tuesday
  • WuXi’s stock has skyrocketed by about tenfold from its IPO price of HK$20.6

Topic |   Pharmaceuticals
WuXi Biologics’ stock was trading 3.1 per cent lower in Hong Kong on Wednesday afternoon. Photo: Sam TsangWuXi Biologics’ stock was trading 3.1 per cent lower in Hong Kong on Wednesday afternoon. Photo: Sam Tsang
WuXi Biologics’ stock was trading 3.1 per cent lower in Hong Kong on Wednesday afternoon. Photo: Sam Tsang
READ FULL ARTICLE
Close
We need your support

Advertising helps us continue to provide quality content. Help support us by disabling your adblocker on our site.

How to whitelist us:
  1. 1
    Click on the AdBlock icon at the top right corner of your browser.
    For iOS, go to Settings/Safari/Content Blockers and turn it off.

    For Android, go to your Ad blocker app/Settings and turn it off.
  2. 2
    Click Enabled on this site until the text reads Disabled on this site.
  3. 2
    Click the cross icon on the top right corner to close this window and refresh the page.
  4. 3
    Click the cross icon on the top right corner to close this window and refresh the page.